Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

264-448 (DH domain)

Relief mechanism

PTM

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5BKC9

Entry ID Method Resolution Chain Position Source
AF-Q5BKC9-F1 Predicted AlphaFoldDB

No variants for Q5BKC9

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5BKC9

No associated diseases with Q5BKC9

4 regional properties for Q5BKC9

Type Name Position InterPro Accession
domain Helicase, C-terminal 306 - 474 IPR001650
domain DEAD/DEAH box helicase domain 117 - 281 IPR011545
domain Helicase superfamily 1/2, ATP-binding domain 111 - 310 IPR014001
domain RNA helicase, DEAD-box type, Q motif 92 - 120 IPR014014

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Membrane
  • Golgi apparatus
  • Cytoplasm, perinuclear region
  • Golgi apparatus, trans-Golgi network
  • Endosome
  • Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
  • Cell projection, dendrite
  • Cytoplasmic vesicle
  • Synapse
  • Cytoplasm, cytoskeleton
  • Translocates from cytoplasm to membranes upon cAMP treatment
  • Localized in recycling endosomes (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
growth cone The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it.
postsynapse The part of a synapse that is part of the post-synaptic cell.

2 GO annotations of molecular function

Name Definition
ephrin receptor binding Binding to an ephrin receptor.
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.

6 GO annotations of biological process

Name Definition
cell differentiation The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
ephrin receptor signaling pathway The series of molecular signals initiated by ephrin binding to its receptor, and ending with the regulation of a downstream cellular process, e.g. transcription.
negative regulation of dendritic spine morphogenesis Any process that decreases the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
nervous system development The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
regulation of GTPase activity Any process that modulates the rate of GTP hydrolysis by a GTPase.
regulation of synapse pruning Any process that modulates the frequency, rate or extent of synapse pruning.

12 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q12774 ARHGEF5 Rho guanine nucleotide exchange factor 5 Homo sapiens (Human) EV
Q8IW93 ARHGEF19 Rho guanine nucleotide exchange factor 19 Homo sapiens (Human) SS
Q96DR7 ARHGEF26 Rho guanine nucleotide exchange factor 26 Homo sapiens (Human) SS
O94989 ARHGEF15 Rho guanine nucleotide exchange factor 15 Homo sapiens (Human) SS
A5YM69 ARHGEF35 Rho guanine nucleotide exchange factor 35 Homo sapiens (Human) PR
Q5VV41 ARHGEF16 Rho guanine nucleotide exchange factor 16 Homo sapiens (Human) PR
Q8N5V2 NGEF Ephexin-1 Homo sapiens (Human) EV
Q8BWA8 Arhgef19 Rho guanine nucleotide exchange factor 19 Mus musculus (Mouse) PR
Q3U5C8 Arhgef16 Rho guanine nucleotide exchange factor 16 Mus musculus (Mouse) PR
E9Q7D5 Arhgef5 Rho guanine nucleotide exchange factor 5 Mus musculus (Mouse) SS
Q5FWH6 Arhgef15 Rho guanine nucleotide exchange factor 15 Mus musculus (Mouse) SS
Q8CHT1 Ngef Ephexin-1 Mus musculus (Mouse) SS
10 20 30 40 50 60
MQESQTKSMF VSRALEKILA DKEVKRPQHS QLRRACQVAL DEIKAELEKQ RLGAAAPPKA
70 80 90 100 110 120
NFIEADKYFL PFELACQSKS PRVVSTSLDC LQKLIAYGHI TGNAPDSGAP GKRLIDRIVE
130 140 150 160 170 180
TVCNCFQGPQ TDEGVQLQII KALLTAVTSP HIEIHEGTIL QTVRTCYNIY LASKNLINQT
190 200 210 220 230 240
TAKATLTQML NVIFTRMENQ VLQEARELEK PIQSKPQSPV IQATAGSPKF SRLKQSQAQS
250 260 270 280 290 300
KPTTPEKTEL PNGDHARSSL GKVNSENGEA HRERGSSISG RAEPSGGSDN GAQEVVKDIL
310 320 330 340 350 360
EDVVTSAVKE AAEKQGLPEP DQAPGVPECQ ECTVPPAVDE NSQTNGIADD RQSLSSADNL
370 380 390 400 410 420
EPDAQGHPVA ARFSHILQKD AFLVFRSLCK LSMKPLGEGP PDPKSHELRS KVVSLQLLLS
430 440 450 460 470 480
VLQNAGPVFR SHEMFVTAIK QYLCVALSKN GVSSVPDVFE LSLAIFLTLL SNFKMHLKMQ
490 500 510 520 530 540
IEVFFKEIFL NILETSTSSF EHRWMVIQTL TRICADAQCV VDIYVNYDCD LNAANIFERL
550 560 570 580 590 600
VNDLSKIAQG RSGHELGMTP LQELSLRKKG LECLVSILKC MVEWSKDLYV NPNHQATLGQ
610 620 630 640 650 660
ERLPDQEMGD GKGLDMARRC SVTSVESTVS SGTQTAIPDD PEQFEVIKQQ KEIIEHGIEL
670 680 690 700 710 720
FNKKPKRGIQ FLQEQGMLGA AVEDIAQFLH QEERLDSTQV GEFLGDSTRF NKEVMYAYVD
730 740 750 760 770 780
QLDFCEKEFV SALRTFLEGF RLPGEAQKID RLMEKFAARY IECNQGQTLF ASADTAYVLA
790 800 810 820 830 840
YSIIMLTTDL HSPQVKNKMT KEQYIKMNRG INDSKDLPEE YLSSIYEEIE GKKIAMKETK
850 860 870 880 890 900
EHTMATKSTK QNVASEKQRR LLYNVEMEQM AKTAKALMEA VSHAKAPFTS ATHLDHVRPM
910 920 930 940 950 960
FKLVWTPLLA AYSIGLQNCD DTEVASLCLE GIRCAVRIAC IFGMQLERDA YVQALARFSL
970 980 990 1000 1010 1020
LTASSSITEM KQKNIDTIKT LITVAHTDGN YLGNSWHEIL KCISQLELAQ LIGTGVKTRY
1030 1040 1050 1060 1070 1080
LSGSGREREG SLKGHSLAGE EFMGLGLGNL VSGGVDKRQM ASFQESVGET SSQSVVVAVD
1090 1100 1110 1120 1130 1140
RIFTGSTRLD GNAIVDFVRW LCAVSMDELA SPHHPRMFSL QKIVEISYYN MNRIRLQWSR
1150 1160 1170 1180 1190 1200
IWHVIGDHFN KVGCNPNEDV AIFAVDSLRQ LSMKFLEKGE LANFRFQKDF LRPFEHIMKK
1210 1220 1230 1240 1250 1260
NRSPTIRDMV IRCIAQMVSS QAANIRSGWK NIFAVFHQAA SDHDGNIVEL AFQTTGHIVS
1270 1280 1290 1300 1310 1320
TIFQHHFPAA IDSFQDAVKC LSEFACNAAF PDTSMEAIRL IRFCGKYVSE RPRVLQEYTS
1330 1340 1350 1360 1370 1380
DDMNVAPGDR VWVRGWFPIL FELSCIINRC KLDVRTRGLT VMFEIMKSYG HTFAKHWWQD
1390 1400 1410 1420 1430 1440
LFRIVFRIFD NMKLPEQQSE KSEWMTTTCN HALYAICDVF TQFYEALHEV LLSDVFAQLQ
1450 1460 1470 1480 1490 1500
WCVKQDNEQL ARSGTNCLEN LVISNGEKFS PAVWDETCNC MLDIFRTTIP HVLLTWRPAG
1510 1520 1530 1540 1550 1560
MEEEVSDRHL DVDLDRQSLS SIDRNASERG QSQLSNPTDD SWKGAPYANQ KLLASLLIKC
1570 1580 1590 1600 1610 1620
VVQLELIQTI DNIVFYPATS KKEDAEHMVA AQQDTLDADI HIETENQGMY KFMSSQHLFK
1630 1640 1650 1660 1670 1680
LLDCLQESHS FSKAFNSNYE QRTVLWRAGF KGKSKPNLLK QETSSLACCL RILFRMYVDE
1690 1700 1710 1720 1730 1740
NRRDSWGEIQ QRLLTVCSEA LAYFITVNSE SHREAWTSLL LLLLTKTLKI NDEKFKAHAS
1750 1760 1770 1780 1790
VYYPYLCEMM QFDLIPELRA VLRKFFLRIG LVYKIWVPEE PSQVPAASTA W